Chronic kidney disease and the aging population


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

The proportion of older people in the general population is steadily increasing worldwide, with the most rapid growth in low- and middle-income countries [і]. This demographic change is to be celebrated, because it is the consequence of socioeconomic development and better life expectancy. However, population aging also has important implications for society - in diverse areas including health systems, labor markets, public policy, social programs, and family dynamics [2]. A successful response to the aging population will require capitalizing on the opportunities that this transition offers, as well as effectively addressing its challenges. Chronic kidney disease (CKD) is an important public health problem that is characterized by poor health outcomes and very high health care costs. CKd is a major risk multiplier in patients with diabetes, hypertension, heart disease and stroke - all of which are key causes of death and disability in older people [З]. Since the prevalence of CKD is higher in older people, the health impact of population aging will depend in part on how the kidney community responds. March із, 2014 will mark the celebration of the 9 th World Kidney Day (WKD), an annual event jointly sponsored by the International Society of Nephrology and the International Federation of Kidney Foundations. Since its inception in ZOOS, WKD has become the most successful effort to raise awareness among policymakers and the general public about the importance of kidney disease. The topic for WKd 2014 is “CKD in older people”. This article reviews the key links between kidney function, age, health and illness - and discusses the implications of the aging population for the care of people with CKD.

Texto integral

Acesso é fechado

Sobre autores

M. Tonelli

M. Riella

Bibliografia

  1. World Health Organization. Good health adds life to years: Global brief for World Health Day. - Geneva, 2012.
  2. Wiener J.M., Tilly J. Population ageing in the United States of America: implications for public programmes // Int J Epidemiol. - 2002. - Vol. 31. - P. 776- 781.
  3. Couser W.G., Remuzzi G, Mendis S. et al. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases // Kidney Int. - 2011. - Vol. 80. -P. 1258-1270.
  4. Select Committee on Public Service and Demographic Change. Ready for Aging? Report. House of Lords. - London, 2013.
  5. Davies D.F., Shock N. W. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males // J Clin Invest. - 1950. - Vol. 29. -P. 496-507.
  6. Zhang L, Wang F., Wang L. et al. Prevalence of chronic kidney disease in China: a crosssectional survey // Lancet. - 2012. - Vol. 379. - P. 815-822.
  7. Coresh J., Selvin E., Stevens L.A. et al. Prevalence of chronic kidney disease in the United States// JAMA. - 2007. - Vol. 298. - P. 2038-2047.
  8. Zhang Q.L., Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review // BMC Public Health. - 2008. - Vol. 8. - P. 117.
  9. Arora P., Vasa P., Brenner D. et al. Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey // CMAJ. - 2013. - Vol. 185. -P. E417-423.
  10. James M.T., Hemmelgarn B.R., Tonelli M. Early recognition and prevention of chronic kidney disease // Lancet. - 2010. - Vol. 375. - P. 1296-1309.
  11. Kurella M., Covinsky K.E., Collins A.J. et al. Octogenarians and nonagenarians starting dialysis in the United States // Ann Intern Med. - 2007. - Vol. 146. - P. 177-183.
  12. Hemmelgarn B.R., James M. T., Manns B.J. et al. Rates of treated and untreated kidney failure in older vs younger adults // JAMA. - 2012. - Vol. 307. - P. 2507-2515.
  13. Keith D.S., Nichols G.A., Gullion C.M. et al. Longtudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization // Arch Intern Med. - 2004. - Vol. 164. - P. 659-663.
  14. Hemmelgarn B.R., Manns B.J., Lloyd A. et al. Relation between kidney function, proteinuria, and adverse outcomes // JAMA. - 2010. - Vol. 303. - P. 423-429.
  15. O'Hare A.M., Bertenthal D., Covinsky K.E. et al. Mortality risk stratification in chronic kidney disease: one size for all ages?// J Am Soc Nephrol. - 2006. - Vol. 17. - P. 846-853.
  16. Stevens P.E., Levin A., Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group M. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline // Ann Intern Med. - 2013. - Vol. 158. - P. 825-830.
  17. Thorsteinsdottir B., Montori V.M., Prokop L.J. et al. Ageism vs. the technical imperative, applying the GRADE framework to the evidence on hemodialysis in very elderly patients // Clin Interv Aging. - 2013. - Vol. 8. - P. 797-807.
  18. Chandna S.M., Da Silva-Gane M., Marshall C. et al. Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy // Nephrol Dial Transplant. - 2011. - Vol. 26. - P. 1608-1614.
  19. Murtagh F.E., Marsh J.E., Donohoe P. et al. Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5// Nephrol Dial Transplant. -2007. - Vol. 22. - P. 1955-1962.
  20. Kurella Tamura M., Covinsky K.E., Chertow G.M. et al. Functional status ofelderly adults before and after initiation of dialysis//N Engl J Med. - 2009. - Vol. 361. - P. 1539-1547.
  21. Lamping D.L., Constantinovici N., Roderick P. et al. Clinical outcomes, quality of life, and costs in the North Thames Dialysis Study of elderly people on dialysis: a prospective cohort study // Lancet. - 2000. - Vol. 356. - P. 1543-1550.
  22. Unruh M.L., Newman A.B., Larive B. et al. The influence of age on changes in health-related quality of life over three years in a cohort undergoing hemodialysis // J Am Geriatr Soc. - 2008. - Vol. 56. - P. 1608-1617.
  23. Knoll G.A. Kidney transplantation in the older adult // Am J Kidney Dis. - 2013. -Vol. 61. - P. 790-797.
  24. Merion R.M., Ashby V.B., Wolfe R.A. et al. Deceased-donor characteristics and the survival benefit ofkidney transplantation //JAMA. - 2005. - Vol. 294. - P. 2726-2733.
  25. Cohen B., Smits J.M., Haase B. et al. Expanding the donor pool to increase renal transplantation // Nephrol Dial Transplant. - 2005. - Vol. 20. - P. 34-41.
  26. Gill J., Bunnapradist S., Danovitch G.M. et al. Outcomes of kidney transplantation from older living donors to older recipients //Am J Kidney Dis. - 2008. - Vol. 52 - P. 541-552.
  27. Gill J.S., Tonelli M., Johnson N. et al. The impact of waiting time and comorbid conditions on the survival benefit of kidney transplantation // Kidney Int. - 2005. - Vol. 68. -P. 2345-2351.
  28. O'Hare A.M., Kaufman J.S., Covinsky K.E. et al. Curent guidelines for using angiotensinconverting enzyme inhibitors and angiotensin II-receptor antagonists in chronic kidney disease: is the evidence base relevant to older adults? // Ann Intern Med. - 2009. - Vol. 150. - P. 717-724.
  29. Mohanlal V., Weir M. Kidney Transplantation in the Elderly: Its Not AU Gloom and Doom // ASN Kidney News. - 2011. - Vol. 3. - P. 15-17.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar